Clinical Trial Update: IT and IV Lentiviral Gene Therapy for X-ALD [NA]

View source ↗

Summary

Clinical trial update indicates a lentiviral gene therapy delivered intrathecally and intravenously for X-linked Adrenoleukodystrophy is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• X-linked Adrenoleukodystrophy

Drugs mentioned

• Lentiviral gene therapy for X-ALD (intrathecal and intravenous delivery)

Snippet

Sponsor: Shenzhen Geno-Immune Medical Institute | Conditions: X-linked Adrenoleukodystrophy | NA | Status: RECRUITING